Integrated Treatment With Stapled Haemorrhoidopexy and Proctonorm® of Haemorrhoidal Disease.


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 10 05 2019
revised: 11 06 2019
accepted: 13 06 2019
entrez: 1 9 2019
pubmed: 1 9 2019
medline: 6 2 2020
Statut: ppublish

Résumé

This retrospective study was performed in patients undergoing Stapled Haemorrhoidopexy (SH) who were post-operatively treated with Proctonorm® with the aim of assessing its effect on early and late haemorrhoidal-related symptoms. Forty-six males and 54 females received Proctonorm® (one tablet twice daily for 14 days) and Ketoprofene R (200 mg, one tablet twice daily, as requested). "Early Complication Score" (0-12) two days after surgery was 2.02±1.03; pain VAS (Visual Analogue Scale) (0-10) was 1.21±0.89, and the number of anti-inflammatory tablets was 4.24±1.06. At 40-day post-operative assessment, seven patients had post-operative complications with "Late Complication Score" (0-20) of 0.34±0.68. At six-month follow-up, a high index of patient satisfaction (VAS=9.39±0.24) was self-reported with 75% reduction in CSS (Constipation Scoring System) (1.95±2.58) compared to preoperative scores; "Late Complication Score" was 0. The specific target activity of Proctonorm® at the microcircular level may be effective in patients undergoing SH in order to reduce the inflammatory response of residual haemorrhoids while waiting for stable resolution of symptoms within one or two weeks.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
This retrospective study was performed in patients undergoing Stapled Haemorrhoidopexy (SH) who were post-operatively treated with Proctonorm® with the aim of assessing its effect on early and late haemorrhoidal-related symptoms.
PATIENTS AND METHODS METHODS
Forty-six males and 54 females received Proctonorm® (one tablet twice daily for 14 days) and Ketoprofene R (200 mg, one tablet twice daily, as requested).
RESULTS RESULTS
"Early Complication Score" (0-12) two days after surgery was 2.02±1.03; pain VAS (Visual Analogue Scale) (0-10) was 1.21±0.89, and the number of anti-inflammatory tablets was 4.24±1.06. At 40-day post-operative assessment, seven patients had post-operative complications with "Late Complication Score" (0-20) of 0.34±0.68. At six-month follow-up, a high index of patient satisfaction (VAS=9.39±0.24) was self-reported with 75% reduction in CSS (Constipation Scoring System) (1.95±2.58) compared to preoperative scores; "Late Complication Score" was 0.
CONCLUSION CONCLUSIONS
The specific target activity of Proctonorm® at the microcircular level may be effective in patients undergoing SH in order to reduce the inflammatory response of residual haemorrhoids while waiting for stable resolution of symptoms within one or two weeks.

Identifiants

pubmed: 31471422
pii: 33/5/1671
doi: 10.21873/invivo.11654
pmc: PMC6755022
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1671-1675

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

Life Sci. 2006 Dec 14;80(2):146-53
pubmed: 17011589
Dis Colon Rectum. 1996 Jun;39(6):681-5
pubmed: 8646957
Surg Res Pract. 2016;2016:2906145
pubmed: 26998510
Biotechnol Res Int. 2012;2012:976203
pubmed: 23304525
Br J Surg. 2001 Aug;88(8):1049-53
pubmed: 11488788
Dis Colon Rectum. 2007 Jun;50(6):878-92
pubmed: 17380367
Am J Surg. 2001 Jul;182(1):64-8
pubmed: 11532418
Lancet. 2000 Aug 26;356(9231):730-3
pubmed: 11085693
J Neurosci. 2009 Jul 29;29(30):9500-9
pubmed: 19641113
Br J Surg. 2001 Nov;88(11):1449-55
pubmed: 11683739
Lancet. 2000 Mar 4;355(9206):782-5
pubmed: 10711925
J Med Assoc Thai. 2004 Feb;87(2):137-42
pubmed: 15061296
Br J Surg. 2006 Feb;93(2):226-30
pubmed: 16323166
Colorectal Dis. 2007 May;9(4):352-6
pubmed: 17432989
Br J Surg. 1994 Jul;81(7):946-54
pubmed: 7922085
Arch Surg. 2002 Dec;137(12):1395-406; discussion 1407
pubmed: 12470107
Chir Ital. 2007 Jul-Aug;59(4):527-32
pubmed: 17966775
Dis Colon Rectum. 2009 Sep;52(9):1598-604
pubmed: 19690488

Auteurs

Giuliano Reboa (G)

Department of Surgery, Coloproctology Unit - Casa di Cura San Camillo, Forte dei Marmi (Lucca), Italy.

Marco Gipponi (M)

Breast Surgery Clinic, Osp. Policlinico San Martino, Genoa, Italy marco.gipponi@hsanmartino.it.

Piero Fregatti (P)

Breast Surgery Clinic, Osp. Policlinico San Martino, Genoa, Italy.
School of Medicine, University of Genoa, Genoa, Italy.

Francesca Depaoli (F)

Breast Surgery Unit, Azienda Sanitaria Locale 3, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH